Dario Amodei, CEO and co-founder at Anthropic, sits down with Diogo Rau, Chief Information and Digital Officer at Eli Lilly and Company, to discuss building enterprise AI for regulated industries like life sciences.
In his role at Lilly, Diogo is responsible for setting the pharmaceutical leader’s AI strategy, including how organizations use models like Claude to power clinical research and drug development.
The two discuss Anthropic’s approach to building more steerable and reliable AI for enterprise deployments, our commitment to creating more skills for life sciences use cases, and the importance of building specialized models to power industry-specific solutions.
Learn more about what Claude can do for life sciences: https://claude.com/solutions/life-sciences
